成都血管瘤哪里治得好(成都什么医院做精索静脉曲张技术好) (今日更新中)

Although thousands of people learn CPR, women are less likely than men to get CPR from a bystander. And they are more likely to die.A new study found only 39 percent of women suffering cardiac arrest in a public place were given CPR versus 45 percent of men. And men were 23 percent more likely to survive."It's not hugely surprising but rather anyone that has a different body type than this adult male half mannequin of a person we're going to have some hesitation when we figure out how to handle that situation," says Stephen Wolfstich, CEO of Remote Emergency Services + Training.Wolfstich says because of that, people often have questions before starting CPR on women. "Do I remove their shirt?" Wolfstich says. "Do I remove their bra? What's my hand placement? Is it appropriate for me to be putting my hands on a female chest? Are there bystanders around and how are they going to react and where does my liability stand."He tells students they are protected by the Good Samaritan Law. And CPR only requires touching the center of the chest."You're not actually pressing down on the breast," Wolfstich says. "It is not going to injure anything, you're putting all of your weight directly onto that breastbone."He and other experts say instruction must be more inclusive, and there is no time to waste."Us simply hesitating on do I want to put my hands on their chest that could be five or 10 seconds, "Woldstich says. "15, 20 seconds that goes by where we decide for ourselves is this okay with me. "Well if too much time goes by it's not okay with either one of them."The study is in the Journal of the American College of Cardiology. It involved nearly 20,000 cases across the U.S. It's the first to look at the response when it comes to helping men compared to women by the general public. 1823

Almost a decade ago, Matt Wilson went to the emergency room after experiencing a lot of pain. It was pretty clear he had a kidney stone, but the doctors wanted to take a look to be sure.“After they identified the kidney stone, they told me I had a shadow in my pancreas," said Wilson.That shadow would lead to a few months without answers.“Went through testing and went through months of tests without knowing what it is, but they wouldn’t rule anything out. The months of not knowing were stressful. They were stressful on me, they were on my family,” said Wilson.Finally, after visiting a specialist in Philadelphia, he finally got an answer.“They said I had a cancerous tumor on the tail of my pancreas. I went in for a kidney stone and came out with a diagnosis of pancreatic cancer,” he recalled.Wilson knew he wanted to fight. He underwent surgery to remove part of his pancreas, his spleen, and 21 lymph nodes.Wilson has survived for nine years since his diagnosis. According to the American Cancer Association, the five-year survival rate for pancreatic cancer is just 9 percent.“It is one of the deadliest cancers,” said Julie Fleshman, the CEO of the Pancreatic Cancer Action Network. The group raises money and awareness for pancreatic cancer. She wants people to know why it’s such a hard disease to detect.“The symptoms of pancreatic cancer are quite vague. There’s things like stomach pain and back pain, unexplained weight loss. Things that could be associated with other diseases, so it’s not usually the first thing that someone thinks of as oh, maybe it’s pancreatic cancer,” said Fleshman.In addition to unclear symptoms, there’s no early detection test like you might have with other cancers."Usually, by the time it’s diagnosed, it’s late stage. It’s already metastasized or spread to other organs, and it’s more difficult to treat at that point,” said Fleshman.But Fleshman and Wilson hope the efforts of organizations like PanCan will lead to an early detection test and more treatments to help save lives.“I actually really think that it’s possible that in the next decade for us to have an early detection strategy,” said Fleshman.“My hope is that we continue to make advances. That we can have early detection for people for pancreatic cancer in the future, and I think we will get there. And that will continue to improve patient outcomes and improve the survival rate of this disease,” said Wilson. 2435

Actor Jeff Bridges gave an update on his battle against lymphoma this week, showing off a bald head and a new puppy.The 71-year-old announced in October he had been diagnosed with lymphoma, and said at the time his prognosis was good and he promised to keep fans updated.In an Instagram post Monday, Bridges said he was “feeling good” while sitting outside holding his new puppy.“Here’s the latest:? Feeling good? Shaved my head? Got a puppy - Monty? Had a Birthday - 71, man”https://www.instagram.com/p/CIygGEBAxg8/Bridges posted a longer message on his personal site, which included a plea to help support musicians who are struggling to get gigs and make ends meet during the pandemic.He also directed fans to No Kid Hungry, saying “the health of our children can serve as a compass, letting us know if we’re on course or not - we’re off course.”In an earlier update on his treatment, the day before Halloween, Bridges shared an image of himself getting chemotherapy. 978

Actor Will Smith, who became a household name after starring in “The Fresh Prince of Bel-Air,” shared photos from a cast reunion celebrating 30 years since the show launched.The actor posted, “Today is exactly 30 YEARS since The @FreshPrince of Bel-Air debuted! So we’re doin’ something for y’all… a for real Banks Family Reunion is comin’ soon to @HBOmax! RIP James. #FreshPrince30th” with a photo of the cast reunited. 428

About 30,000 doses of an experimental coronavirus treatment are shipping out Tuesday.It's Regeneron's antibody cocktail that got an emergency use authorization (EUA) from the Food and Drug Administration (FDA) over the weekend. It’s also the same treatment President Donald Trump got last month.Patients who are diagnosed early with COVID-19 may be eligible. The goal is to keep them from getting sicker, so they don't have to go to the hospital.But the treatment still needs to be given through an IV.“The challenge is there has to be a place to administer it, so a place where you can have COVID patients in an infusion setting where they can be treated and monitored. This is not straight-forward,” said Dr. Helen Boucher, Chief of Geographic Medicine and Infectious Diseases at Tufts Medical Center.Any transfusion centers administering the IV will charge for those services.“The medicine itself is paid for by the government right now under the emergency use authorization. Those other charges have to be managed and they'll be managed by insurance, Medicare or Medicaid,” said Boucher.It's unclear if patients will need to request the treatment or if doctors will choose who to prescribe it to.In trying to get it to areas that need it most, the federal government will work with states on distribution. The problem is everywhere is seeing spikes right now.“We know that at least for 2020, the supply is going to be very low, so many of us in the infectious disease community and all the health care community are concerned that this resource will be allocated in an equitable way,” said Boucher.After this initial rollout, Regeneron says it expects to have 80,000 doses ready by the end of the month, 200,000 by the first week of January, and then 300,000 by the end of that month. 1796

来源：资阳报